NEW YORK STATE COMMON RETIREMENT FUND DRUG — BRIGHT MINDS BIOSCIENCES

Ownership history in NEW YORK STATE COMMON RETIREMENT FUND  ·  4 quarters on record

AI Ownership Summary

NEW YORK STATE COMMON RETIREMENT FUND reported BRIGHT MINDS BIOSCIENCES (DRUG) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. The latest visible filing shows DRUG at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this DRUG ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was NEW YORK STATE COMMON RETIREMENT FUND's position in BRIGHT MINDS BIOSCIENCES, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

DRUG was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

DRUG stock page NEW YORK STATE COMMON RETIREMENT FUND fund profile NEW YORK STATE COMMON RETIREMENT FUND full holdings
How NEW YORK STATE COMMON RETIREMENT FUND held DRUG — position size vs. price
% of Fund (quarterly)    DRUG price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 2,600 — 0% 0.00% $190K 2026-05-06 $88.90
2025 Q4 UNCHANGED — — — 2,600 — 0% 0.00% $203K 2026-02-12 $80.57
2025 Q3 REDUCED 36.6% +28.8% ❌ 2,600 -1,500 -36.6% 0.00% $158K 2025-11-03 $51.46
2025 Q2 INITIATED — — — 4,100 — — 0.00% $107 2025-08-13 $40.54

🏢 Other funds also holding DRUG

As of 2026 Q1 — sorted by position size

ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 5.76% Cormorant Asset Management, LP 3Y 7Y 3.88% GREAT POINT PARTNERS LLC 3Y 7Y 3.69% B Group, Inc. 3.65% Vivo Capital, LLC 3Y 7Y 3.39% KVP Capital Advisors, LP 1.73% BRAIDWELL LP 3Y 1.31% MPM BioImpact LLC 3Y 1.2% Vestal Point Capital, LP 1.0% Ikarian Capital, LLC 3Y 0.99%

FAQ About NEW YORK STATE COMMON RETIREMENT FUND and DRUG

These are the practical questions this page is built to answer before you even open the full history table.

How long has NEW YORK STATE COMMON RETIREMENT FUND reported owning DRUG?

NEW YORK STATE COMMON RETIREMENT FUND reported DRUG across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported DRUG position in NEW YORK STATE COMMON RETIREMENT FUND's portfolio?

The largest reported portfolio weight for DRUG was 0.00% in 2025 Q4.

What is the latest reported DRUG position on this page?

The most recent filing on this page is 2026 Q1, when NEW YORK STATE COMMON RETIREMENT FUND reported 2,600 shares, equal to 0.00% of portfolio, with an estimated market value of $190K.

What does the chart on this DRUG ownership page compare?

The chart compares NEW YORK STATE COMMON RETIREMENT FUND's quarterly DRUG portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to NEW YORK STATE COMMON RETIREMENT FUND Holdings